Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.
$599
Posted in: Bolus Insulin, Insulin Delivery, Topics Aug 03 | 2018MannKind Q2 ’18 Earnings UpdatePurchase Blast
$599
Posted in: SGLT2i, Topics Aug 02 | 2018Invokana Receives Positive CHMP Opinion for CV IndicationPurchase Blast
$599
Posted in: Insulin Delivery, Topics Aug 02 | 2018BD Patch Pump Update; CY Q2 ’18 Earnings (FY Q3 ’18)Purchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Topics Aug 01 | 2018Lilly’s New Diabetes Helpline to Aid Insulin AccessPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, GLP-1RA + Basal, Topics Jul 31 | 2018Sanofi Q2 ’18 Earnings Update; Pfizer Discontinues Ph1 T1DM CompoundPurchase Blast
$599
Posted in: GLP-1RA, Topics Jul 30 | 2018New Ozempic Concentrations; Potential Autoinjector in Ph1 StudyPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, DPP-IVi, SGLT2i, Topics Jul 27 | 2018Biocon/Mylan Glargine CRL; Biocon and Merck Q2 ’18 EarningsPurchase Blast
$599
Posted in: Glucose Monitoring, Topics Jul 27 | 2018New Abbott Libre 14-Day Wear, 1-Hour Warm-up and Improved MARD ApprovedPurchase Blast
$599
Posted in: DPP-IVi, Dual/triple agonist, GLP-1RA, SGLT2i, Topics Jul 26 | 2018AZ Q2 ’18 Earnings UpdatePurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery, Topics Jul 26 | 2018Roche Q2 '18 Earnings UpdatePurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, DPP-IVi, Dual/triple agonist, GLP-1RA, Glucagon, Insulin Delivery, Other, SGLT2i, Topics Jul 24 | 2018LLY Dual Agonist Advances to Ph3; Q2 ’18 Earnings UpdatePurchase Blast
$599
Posted in: Glucagon, Topics Jul 23 | 2018Glucagon: Thoughts on Mylan Generic and Novel Launch TimingsPurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery, Topics Jul 23 | 2018Roche Patch Pump CE MarkedPurchase Blast
$599
Posted in: DPP-IVi, Topics Jul 19 | 2018CARMELINA CVOT Neutral; No Mention of SuperiorityPurchase Blast
$599
Posted in: Glucose Monitoring, SGLT2i, Topics Jul 18 | 2018Novartis Discontinues LIK066 in obesity; Novartis and Abbott Q2 '18 Earnings UpdatesPurchase BlastGet the Latest Analysis
Stay informed and aligned with frequent updates to keep a pulse on the industry.
If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.
